Tista' taqra bil- Malti.
The European Union entered in its sixth contract with a pharmaceutical company for another 160 million vaccines. This was announced by European Commission President Ursula von der Leyen.
‘I am happy to announce that today, we approved a new contract to secure another COVID-19 vaccine for Europeans’, declared the Head of the European Commission.
The contract allows the up to 160 million doses of a vaccine produced by Moderna.
This is the sixth contract with a pharmaceutical company for the European Union’s COVID-19 vaccines portfolio. All vaccines from our portfolio will be evaluated very carefully by the European Medicines Agency (EMA). They will only be authorised and placed on the market if they are safe and effective.
‘Securing rapidly vaccines for Europeans is the Commission’s priority’, continued Ursula von der Leyen.
The European Union is also committed to support the UN efforts for COVAX, with the aim to secure vaccines for low- and middle-income countries. The EU have raised €16 billion since May for tests, treatments, and vaccines against coronavirus worldwide.